iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer

{{article.zuoZheEn}}

PDF(219 KB)
PDF(219 KB)
Front. Med. ›› 2016, Vol. 10 ›› Issue (3) : 278-285. DOI: 10.1007/s11684-016-0453-z
RESEARCH ARTICLE

iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2016, 10(3): 278‒285 https://doi.org/10.1007/s11684-016-0453-z

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(219 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉